Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-061898
Filing Date
2006-03-23
Accepted
2006-03-23 16:57:39
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1006601
2 MANUFACTURE, LICENSE AND DISTRIBUTION AGREEMENT DATED OCTOBER 20, 2005 dex1033.htm EX-10.33 122418
3 FIRST AMENDMENT TO LEASE, EFFECTIVE AS OF OCTOBER 12, 2005 dex1035.htm EX-10.35 25968
4 DEVELOPMENT AND LICENSE AGREEMENT DATED DECEMBER 21, 2005 dex1037.htm EX-10.37 250393
5 CONSENT OF GRANT THORTON LLP dex231.htm EX-23.1 2085
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 10064
7 CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 10056
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3984
9 CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. dex322.htm EX-32.2 4029
  Complete submission text file 0001193125-06-061898.txt   1437308
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)

EIN.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31982 | Film No.: 06706635
SIC: 2835 In Vitro & In Vivo Diagnostic Substances